APO RESEARCH · REPORT
Organ-on-Chip
An organ-on-a-chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-on-a-chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Product & engineering
Understand the product.
An organ-on-a-chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-on-a-chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Selected research
Industry Research
Organ-on-Chip Industry Research Report 2026
Market perspective
An organ-on-a-chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-on-a-chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Global Organ-on-Chip key players include Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems, etc. Global top five manufacturers hold a share about 55%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
Read the full market overview
In terms of product, Liver-on-a-chip is the largest segment, with a share about 30%. And in terms of application, the largest application is Pharmaceutical & Biotechnology Companies, followed by Academic & Research Institutes.
Report Scope
This report quantifies the global Organ-on-Chip market in revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Organ-on-Chip.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Organ-on-Chip Market by Company
Emulate
TissUse
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Organ-on-Chip Segment by Type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Others
Organ-on-Chip Segment by End Users
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Cosmetics Industry
Other End Users
Organ-on-Chip Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Organ-on-Chip market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Organ-on-Chip and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Organ-on-Chip.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Organ-on-Chip manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Organ-on-Chip by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Organ-on-Chip in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by end users, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Brain-on-a-chip
- Liver-on-a-chip
- Kidney-on-a-chip
- Lung-on-a-chip
- Heart-on-a-chip
- Intestine-on-a-chip
- Others
Applications
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Cosmetics Industry
- Other End Users
Companies covered
- Emulate
- TissUse
- Hesperos
- CN Bio Innovations
- Tara Biosystems
- Draper Laboratory
- Mimetas
- Nortis
- Micronit Microtechnologies B.V.
- Kirkstall
- Cherry Biotech SAS
- Else Kooi Laboratory
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Organ-on-Chip by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Brain-on-a-chip
- 2.2.3 Liver-on-a-chip
- 2.2.4 Kidney-on-a-chip
- 2.2.5 Lung-on-a-chip
- 2.2.6 Heart-on-a-chip
- 2.2.7 Intestine-on-a-chip
- 2.2.8 Others
- 2.3 Organ-on-Chip by End Users
- 2.3.1 Market Value Comparison by End Users (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pharmaceutical and Biotechnology Companies
- 2.3.3 Academic and Research Institutes
- 2.3.4 Cosmetics Industry
- 2.3.5 Other End Users
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Organ-on-Chip Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Organ-on-Chip Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Organ-on-Chip Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Organ-on-Chip Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Organ-on-Chip Production by Manufacturers (2021-2026)
- 3.2 Global Organ-on-Chip Production Value by Manufacturers (2021-2026)
- 3.3 Global Organ-on-Chip Average Price by Manufacturers (2021-2026)
- 3.4 Global Organ-on-Chip Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Organ-on-Chip Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Organ-on-Chip Manufacturers, Product Type & Application
- 3.7 Global Organ-on-Chip Manufacturers Established Date
- 3.8 Global Organ-on-Chip Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Emulate
- 4.1.1 Emulate Organ-on-Chip Company Information
- 4.1.2 Emulate Organ-on-Chip Business Overview
- 4.1.3 Emulate Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 4.1.4 Emulate Product Portfolio
- 4.1.5 Emulate Recent Developments
- 4.2 TissUse
- 4.2.1 TissUse Organ-on-Chip Company Information
- 4.2.2 TissUse Organ-on-Chip Business Overview
- 4.2.3 TissUse Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 4.2.4 TissUse Product Portfolio
- 4.2.5 TissUse Recent Developments
- 4.3 Hesperos
- 4.3.1 Hesperos Organ-on-Chip Company Information
- 4.3.2 Hesperos Organ-on-Chip Business Overview
- 4.3.3 Hesperos Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 4.3.4 Hesperos Product Portfolio
- 4.3.5 Hesperos Recent Developments
- 4.4 CN Bio Innovations
- 4.4.1 CN Bio Innovations Organ-on-Chip Company Information
- 4.4.2 CN Bio Innovations Organ-on-Chip Business Overview
- 4.4.3 CN Bio Innovations Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 4.4.4 CN Bio Innovations Product Portfolio
- 4.4.5 CN Bio Innovations Recent Developments
- 4.5 Tara Biosystems
- 4.5.1 Tara Biosystems Organ-on-Chip Company Information
- 4.5.2 Tara Biosystems Organ-on-Chip Business Overview
- 4.5.3 Tara Biosystems Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 4.5.4 Tara Biosystems Product Portfolio
- 4.5.5 Tara Biosystems Recent Developments
- 4.6 Draper Laboratory
- 4.6.1 Draper Laboratory Organ-on-Chip Company Information
- 4.6.2 Draper Laboratory Organ-on-Chip Business Overview
- 4.6.3 Draper Laboratory Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 4.6.4 Draper Laboratory Product Portfolio
- 4.6.5 Draper Laboratory Recent Developments
- 4.7 Mimetas
- 4.7.1 Mimetas Organ-on-Chip Company Information
- 4.7.2 Mimetas Organ-on-Chip Business Overview
- 4.7.3 Mimetas Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 4.7.4 Mimetas Product Portfolio
- 4.7.5 Mimetas Recent Developments
- 4.8 Nortis
- 4.8.1 Nortis Organ-on-Chip Company Information
- 4.8.2 Nortis Organ-on-Chip Business Overview
- 4.8.3 Nortis Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 4.8.4 Nortis Product Portfolio
- 4.8.5 Nortis Recent Developments
- 4.9 Micronit Microtechnologies B.V.
- 4.9.1 Micronit Microtechnologies B.V. Organ-on-Chip Company Information
- 4.9.2 Micronit Microtechnologies B.V. Organ-on-Chip Business Overview
- 4.9.3 Micronit Microtechnologies B.V. Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 4.9.4 Micronit Microtechnologies B.V. Product Portfolio
- 4.9.5 Micronit Microtechnologies B.V. Recent Developments
- 4.10 Kirkstall
- 4.10.1 Kirkstall Organ-on-Chip Company Information
- 4.10.2 Kirkstall Organ-on-Chip Business Overview
- 4.10.3 Kirkstall Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 4.10.4 Kirkstall Product Portfolio
- 4.10.5 Kirkstall Recent Developments
- 4.11 Cherry Biotech SAS
- 4.11.1 Cherry Biotech SAS Organ-on-Chip Company Information
- 4.11.2 Cherry Biotech SAS Organ-on-Chip Business Overview
- 4.11.3 Cherry Biotech SAS Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 4.11.4 Cherry Biotech SAS Product Portfolio
- 4.11.5 Cherry Biotech SAS Recent Developments
- 4.12 Else Kooi Laboratory
- 4.12.1 Else Kooi Laboratory Organ-on-Chip Company Information
- 4.12.2 Else Kooi Laboratory Organ-on-Chip Business Overview
- 4.12.3 Else Kooi Laboratory Organ-on-Chip Production, Value and Gross Margin (2021-2026)
- 4.12.4 Else Kooi Laboratory Product Portfolio
- 4.12.5 Else Kooi Laboratory Recent Developments
5 Global Organ-on-Chip Production by Region
- 5.1 Global Organ-on-Chip Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Organ-on-Chip Production by Region: 2021-2032
- 5.2.1 Global Organ-on-Chip Production by Region: 2021-2026
- 5.2.2 Global Organ-on-Chip Production Forecast by Region (2027-2032)
- 5.3 Global Organ-on-Chip Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Organ-on-Chip Production Value by Region: 2021-2032
- 5.4.1 Global Organ-on-Chip Production Value by Region: 2021-2026
- 5.4.2 Global Organ-on-Chip Production Value Forecast by Region (2027-2032)
- 5.5 Global Organ-on-Chip Market Price Analysis by Region (2021-2026)
- 5.6 Global Organ-on-Chip Production and Value, YOY Growth
- 5.6.1 North America Organ-on-Chip Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Organ-on-Chip Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Organ-on-Chip Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Organ-on-Chip Production Value Estimates and Forecasts (2021-2032)
- 5.6.5 South Korea Organ-on-Chip Production Value Estimates and Forecasts (2021-2032)
6 Global Organ-on-Chip Consumption by Region
- 6.1 Global Organ-on-Chip Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Organ-on-Chip Consumption by Region (2021-2032)
- 6.2.1 Global Organ-on-Chip Consumption by Region: 2021-2026
- 6.2.2 Global Organ-on-Chip Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Organ-on-Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Organ-on-Chip Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Organ-on-Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Organ-on-Chip Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Organ-on-Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Organ-on-Chip Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Organ-on-Chip Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Organ-on-Chip Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Organ-on-Chip Production by Type (2021-2032)
- 7.1.1 Global Organ-on-Chip Production by Type (2021-2032) & (K Units)
- 7.1.2 Global Organ-on-Chip Production Market Share by Type (2021-2032)
- 7.2 Global Organ-on-Chip Production Value by Type (2021-2032)
- 7.2.1 Global Organ-on-Chip Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Organ-on-Chip Production Value Market Share by Type (2021-2032)
- 7.3 Global Organ-on-Chip Price by Type (2021-2032)
8 Segment by End Users
- 8.1 Global Organ-on-Chip Production by End Users (2021-2032)
- 8.1.1 Global Organ-on-Chip Production by End Users (2021-2032) & (K Units)
- 8.1.2 Global Organ-on-Chip Production Market Share by End Users (2021-2032)
- 8.2 Global Organ-on-Chip Production Value by End Users (2021-2032)
- 8.2.1 Global Organ-on-Chip Production Value by End Users (2021-2032) & (US$ Million)
- 8.2.2 Global Organ-on-Chip Production Value Market Share by End Users (2021-2032)
- 8.3 Global Organ-on-Chip Price by End Users (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Organ-on-Chip Value Chain Analysis
- 9.1.1 Organ-on-Chip Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Organ-on-Chip Production Mode & Process
- 9.2 Organ-on-Chip Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Organ-on-Chip Distributors
- 9.2.3 Organ-on-Chip Customers
10 Global Organ-on-Chip Analyzing Market Dynamics
- 10.1 Organ-on-Chip Industry Trends
- 10.2 Organ-on-Chip Industry Drivers
- 10.3 Organ-on-Chip Industry Opportunities and Challenges
- 10.4 Organ-on-Chip Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst